News

Using the same approach they recently used to create effective vaccine candidates against COVID-19 and respiratory syncytial virus (RSV), scientists are tackling another virus: the tick-borne Crimean-Congo hemorrhagic fever (CCHF). It causes death in up to 40% of cases, and the World Health Organization identified the disease as one of its top priorities for research and development. The results appear today in the journal Science.

Austin Mayor Steve Adler, Medical Director Desmar Walkes, world-changing scientists and members of the UT Austin Community are gathering to celebrate the hard-working people on campus and beyond who have contributed to COVID-19 vaccines and vaccinations. The College of Natural Sciences' Vaccination Celebration recognizes the UT Austin connection to vaccine development and the progress that has been made in getting people vaccinated almost one year since the global vaccine rollout began. The event also features a vaccine pop-up, as well as a free concert by Austin-based band Nané.

Janice Fischer, professor of molecular biosciences and director of the Biology Instructional Office at The University of Texas at Austin, has won a UT System Regents' Outstanding Teaching Award.

Jason McLellan, UT Austin molecular biosciences professor, has received the 2021 Shirley Bird Perry Longhorn Citizenship Award, recognizing the wide-reaching impact of his work with viral proteins, especially his contributions to COVID-19 vaccines. The award is given annually by UT Austin's Annette Strauss Institute for Civic Life.

Funded by the Stengl-Wyer Endowment, the Stengl Wyer Postdoctoral Scholars Program provides up to three years of independent support for talented postdoctoral researchers in the broad area of the diversity of life and/or organisms in their natural environments. The endowment also supports year-long fellowships for doctoral candidates pursuing dissertation research in the same area.

The Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded grants to six faculty members at The University of Texas at Austin, including Xioalu "Lulu" Cambronne in the Department of Molecular Biosciences. The funding will support ongoing, innovative cancer research at UT Austin and enable advances in immunotherapy, drug development and cancer prevention efforts.

Imagine biological and chemical imaging tools so advanced that they are able to show the molecular details of a virus as it attaches to and enters cells, or the alignment of vanishingly tiny crystals at an atomic level so as to lend insights for new solar energy technology.

Antibiotic resistance, where disease-causing bacteria evolve resistance to drugs that usually kill them, is a rising problem globally, meaning new antibiotics need to be found. However, it is difficult for researchers to know which parts of bacterial cells to target with new drugs.

Despite more than a year and a half of research, there are still many unknowns about how the virus that causes COVID-19 infects human cells. A deeper understanding could lead to new treatment approaches.

A typical flu virus is so small that a thousand of them could fit in the width of a human hair.